Skip to content
value.today

Pfenex Inc.

🇺🇸 San Diego, California, USABiotechnologyFounded 2009
Total raised
$24 M
1 round on record
Latest round
$24 M
Dec 2009
First round on record
Dec 2009
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Pfenex Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2009$24 MNo. 1$10 to $50 million

Pfenex Inc.: Raise no. 1, Dec 2009

Investors in this round

5 investors had bought by the notice of Dec 9, 2009: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 3 investors are named for Pfenex Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$24 M of $24 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bertrand C. Liang · Executive Officer, Director
  • Charles H. Squires · Executive Officer
  • Henry C. Talbot · Executive Officer
  • Albert C. Hansen · Director
  • Dennis C. Merens · Director
  • James C. Gale · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Issuer offered and sold a total of $130,900 worth of Common Stock, $14,000,000 worth of Series A-1 Participating Preferred Stock and $9,869,100 worth of Series A-2 Participating Preferred Stock, to accredited investors.”
  • On the use of proceeds: “All proceeds applied to working capital.”

Signed by Teo Morca, Attorney-in-Fact. Source: SEC Form D, newest notice filed Dec 9, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Pfenex Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2009).

    SEC Form D · Dec 2009

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Dec 2009

That is all the official record says: Pfenex Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

3 named in official filings. Open an investor to see everything it has backed.

Investors in Pfenex Inc.
InvestorKindAmountRoundRoleSource
Dow Chemical Co /de/Fund or asset managernot statednot statedHeld Series A-1 preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Signet Healthcare Partners Accredited Partnership III LPFund or asset managernot statednot statedHeld Series A-2 preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Signet Healthcare Partners QP Partnership II LPFund or asset managernot statednot statedHeld Series A-2 preferred stock, 10% owner (Form 3, 2014)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 5 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Pfenex Inc.
NameRoleNamed in
Bertrand C. LiangExecutive officerDec 2009
Charles H. SquiresExecutive officerDec 2009
Henry C. TalbotExecutive officerDec 2009
Albert C. HansenDirectorDec 2009
Bertrand C. LiangDirectorDec 2009
Dennis C. MerensDirectorDec 2009
James C. GaleDirectorDec 2009